- Home
- SGD vs PBM Comparison
SGD vs PBM Comparison
Compare SGD & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGD
- PBM
- Stock Information
- Founded
- SGD 2021
- PBM 1994
- Country
- SGD United States
- PBM Canada
- Employees
- SGD N/A
- PBM N/A
- Industry
- SGD
- PBM
- Sector
- SGD
- PBM
- Exchange
- SGD Nasdaq
- PBM NYSE
- Market Cap
- SGD 5.0M
- PBM 4.0M
- IPO Year
- SGD N/A
- PBM N/A
- Fundamental
- Price
- SGD $3.19
- PBM $0.11
- Analyst Decision
- SGD
- PBM
- Analyst Count
- SGD 0
- PBM 0
- Target Price
- SGD N/A
- PBM N/A
- AVG Volume (30 Days)
- SGD 973.1K
- PBM 7.3M
- Earning Date
- SGD 01-01-0001
- PBM 11-02-2024
- Dividend Yield
- SGD N/A
- PBM N/A
- EPS Growth
- SGD N/A
- PBM N/A
- EPS
- SGD N/A
- PBM N/A
- Revenue
- SGD $91,978.00
- PBM N/A
- Revenue This Year
- SGD N/A
- PBM N/A
- Revenue Next Year
- SGD N/A
- PBM N/A
- P/E Ratio
- SGD N/A
- PBM N/A
- Revenue Growth
- SGD N/A
- PBM N/A
- 52 Week Low
- SGD $2.66
- PBM $0.09
- 52 Week High
- SGD $168.40
- PBM $14.55
- Technical
- Relative Strength Index (RSI)
- SGD 34.16
- PBM 36.62
- Support Level
- SGD $2.66
- PBM $0.10
- Resistance Level
- SGD $6.61
- PBM $0.12
- Average True Range (ATR)
- SGD 0.88
- PBM 0.01
- MACD
- SGD -0.20
- PBM 0.01
- Stochastic Oscillator
- SGD 12.50
- PBM 78.65
About SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe & Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partner with third-party equity investors or other developers.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.